Alrex Related Clinical Trials
Alrex� Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC) [Completed]
Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis [Completed]
Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis [Active, not recruiting]
Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5% [Active, not recruiting]
Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis [Completed]
Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye [Completed]
Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [Completed]
Lotemax® Gel 0.5% and Restasis 0.05% in Subjects With Mild or Moderate Keratoconjunctivitis Sicca [Completed]
Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge [Completed]
Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery [Active, not recruiting]
Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery [Completed]
Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery [Completed]
Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [Completed]
Efficacy of Loteprednol Ointment Following Eyelid Surgery [Recruiting]
Intraocular Pressure With Loteprednol and Dexamethasone [Completed]
Use of Loteprednol for Contact Lens Intolerance and Dryness [Enrolling by invitation]
Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection [Withdrawn]
A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin [Completed]
A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5% [Active, not recruiting]
Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery [Completed]
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification [Recruiting]
Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax [Completed]
Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children. [Recruiting]
Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge Model [Completed]
Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery [Completed]
Using in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Steroid Treatment in Dry Eye Disease [Recruiting]
Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis [Completed]
The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease [Recruiting]
Comparison the Effects of Dexamethasone and Loteprednol on Epithelial Healing [Completed]
Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate [Completed]
Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation [Completed]
A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis® [Withdrawn]
Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation [Completed]
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis [Completed]
Pediatric Zylet Safety and Efficacy Study [Completed]
Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty [Completed]
A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery [Recruiting]
Zylet vs TobraDex in Blepharokeratoconjunctivitis [Completed]
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease [Recruiting]
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease [Completed]
Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation [Completed]
Topical Steroid Treatment For Dry Eye [Not yet recruiting]
Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex [Completed]
Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema [Completed]
Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation [Completed]
|